Evidence map›Paper›PMID 42096162›Full record

ArticleEJNMMI research2026

Shuang Liu, Rui Zuo, Mengdan Li, Jing Chen, Jia Li, Xiaoyang Zhang, Qifu Li, Hua Pang, Lu Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shuang Liu *Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Rui Zuo *Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Mengdan LiDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jing ChenDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jia LiDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xiaoyang ZhangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qifu LiDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. liqifu@yeah.net.
Hua PangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Phua1973@163.com.ORCID http://orcid.org/0000-0001-6601-3208
Lu XuDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. lunaxuxu@foxmail.com.ORCID http://orcid.org/0000-0003-0790-147X

Funding

Graduate Supervisor Team for Radionuclide Theranostic Integration Based on Novel Molecular-Targeted Probes 030102050401CYYY-DSTDXM-202420
6 · The paper itself

Abstract

backgroundPrimary aldosteronism (PA) accompanied by subclinical Cushing's syndrome (SCS) complicates both diagnosis and clinical management. This study aimed to investigate the endocrine and metabolic profiles as well as the ⁶⁸Ga‑pentixafor PET/CT imaging features of PA‑SCS, and to evaluate its diagnostic performance for PA‑SCS.

resultsA total of 52 patients with primary aldosteronism who underwent

conclusions⁶⁸Ga‑pentixafor PET/CT is an effective imaging modality for differentiating PA‑SCS from isolated PA, which complements conventional diagnostic. Methods and optimizes early diagnosis and clinical management of PA‑SCS patients.

Indexed as

68Ga-pentixafor PET/CTMolecular imagingPrimary aldosteronism(PA)Subclinical Cushing syndrome(SCS)

Identifiers

PMID42096162
PMCPMC13315395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.